72 related articles for article (PubMed ID: 29146701)
1. Mesangial C4d Deposits in Early IgA Nephropathy.
Segarra A; Romero K; Agraz I; Ramos N; Madrid A; Carnicer C; Jatem E; Vilalta R; Lara LE; Ostos E; Valtierra N; Jaramillo J; Arredondo KV; Ariceta G; Martinez C
Clin J Am Soc Nephrol; 2018 Feb; 13(2):258-264. PubMed ID: 29146701
[TBL] [Abstract][Full Text] [Related]
2. Histological reappraisal of IgA nephropathy: the role of glomerular pattern of injury and mesangial complement deposition.
Obrișcă B; Mocanu V; Jurubiță R; Vrabie A; Berechet A; Lujinschi Ș; Sorohan B; Andronesi A; Achim C; Lupușoru G; Micu G; Caceaune N; Gherghiceanu M; Ismail G
BMC Nephrol; 2024 Apr; 25(1):145. PubMed ID: 38658875
[TBL] [Abstract][Full Text] [Related]
3. IgA nephropathy in children with minimal proteinuria: to biopsy or not to biopsy?
Cambier A; Roy JP; Dossier C; Patey N; Rabant M; Boyer O; Delbet JD; Lapeyraque AL; Hogan J
Pediatr Nephrol; 2024 Mar; 39(3):781-787. PubMed ID: 37698655
[TBL] [Abstract][Full Text] [Related]
4. Mesangial C3 Deposition, Complement-Associated Variant, and Disease Progression in IgA Nephropathy.
Kang Y; Xu B; Shi S; Zhou X; Chen P; Liu L; Li Y; Leng Y; Lv J; Zhu L; Zhang H
Clin J Am Soc Nephrol; 2023 Dec; 18(12):1583-1591. PubMed ID: 37651123
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of C4d expression and staining patterns by immunohistochemistry in renal biopsy samples with focal segmental glomerulosclerosis and minimal change disease.
Abedi M; Nili F; Dehkhoda F; Abdollahi A; Salarvand S
Ann Diagn Pathol; 2024 Jun; 70():152281. PubMed ID: 38417352
[TBL] [Abstract][Full Text] [Related]
6. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
Sarcina C; Tinelli C; Ferrario F; Pani A; De Silvestri A; Scaini P; Del Vecchio L; Alberghini E; Buzzi L; Baragetti I; Pozzi C
Clin J Am Soc Nephrol; 2016 Jun; 11(6):973-981. PubMed ID: 27129712
[TBL] [Abstract][Full Text] [Related]
7. Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy.
Chua JS; Baelde HJ; Zandbergen M; Wilhelmus S; van Es LA; de Fijter JW; Bruijn JA; Bajema IM; Cohen D
J Am Soc Nephrol; 2015 Sep; 26(9):2239-47. PubMed ID: 25573909
[TBL] [Abstract][Full Text] [Related]
8. Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification.
Hirano K; Amano H; Kawamura T; Watanabe K; Koike K; Shimizu A; Endo S; Tsuboi N; Okonogi H; Miyazaki Y; Ikeda M; Hanaoka K; Ogura M; Komatsumoto S; Yokoo T
Clin Exp Nephrol; 2016 Jun; 20(3):425-32. PubMed ID: 26415960
[TBL] [Abstract][Full Text] [Related]
9. Long-term kidney survival analyses in IgA nephropathy patients under steroids therapy: a case control study.
Yuan Y; Wang Q; Ni Z; Che X; Cao L; Shao X; Zhang M; Xie Y; Qi C; Zhou W; Tian L; Mou S
J Transl Med; 2015 Jun; 13():186. PubMed ID: 26048044
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic significance of C4d deposits, as an immunohistochemical proof of complement activation, in kidney glomerular pathologies and kidney transplantation.
Hresko S; Madarova M; Dobosova M; Palusekova N; Niznerova P; Ziaran S; Varga I
Bratisl Lek Listy; 2024; 125(5):275-280. PubMed ID: 38624051
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes in IgA Nephropathy.
Pitcher D; Braddon F; Hendry B; Mercer A; Osmaston K; Saleem MA; Steenkamp R; Wong K; Turner AN; Wang K; Gale DP; Barratt J
Clin J Am Soc Nephrol; 2023 Jun; 18(6):727-738. PubMed ID: 37055195
[TBL] [Abstract][Full Text] [Related]
12. Acteoside relieves mesangial cell injury by regulating Th22 cell chemotaxis and proliferation in IgA nephropathy.
Gan L; Li X; Zhu M; Chen C; Luo H; Zhou Q
Ren Fail; 2018 Nov; 40(1):364-370. PubMed ID: 29708439
[TBL] [Abstract][Full Text] [Related]
13. Medullary sponge kidney with IgA nephropathy: a case report and literature review.
Zeng C; Jin Y; Wang Y; Zhu D; Zhang Z; Wang X
BMC Nephrol; 2024 May; 25(1):154. PubMed ID: 38702597
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids Should Be Used to Treat Slowly Progressive IgA Nephropathy: COMMENTARY.
Campbell KN
Kidney360; 2021 Jul; 2(7):1084-1086. PubMed ID: 35368351
[No Abstract] [Full Text] [Related]
15. Development and External Validation of a Multidimensional Deep Learning Model to Dynamically Predict Kidney Outcomes in IgA Nephropathy.
Chen T; Chen T; Xu W; Liang S; Xu F; Liang D; Li X; Zeng C; Xie G; Liu Z
Clin J Am Soc Nephrol; 2024 May; ():. PubMed ID: 38728096
[No Abstract] [Full Text] [Related]
16. C4d in Proliferative Glomerulonephritis.
Singh G
Indian J Nephrol; 2021; 31(2):93-94. PubMed ID: 34267428
[No Abstract] [Full Text] [Related]
17. Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.
Kawasaki Y; Maeda R; Ohara S; Suyama K; Hosoya M
Pediatr Int; 2018 Feb; 60(2):162-167. PubMed ID: 29178575
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing of complement and coagulation pathways in patients with severe hypertension and renal microangiopathy.
Larsen CP; Wilson JD; Best-Rocha A; Beggs ML; Hennigar RA
Mod Pathol; 2018 Mar; 31(3):488-494. PubMed ID: 29148534
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of mesangial C3 and C4d deposition in IgA nephropathy.
Nam KH; Joo YS; Lee C; Lee S; Kim J; Yun HR; Park JT; Chang TI; Ryu DR; Yoo TH; Chin HJ; Kang SW; Jeong HJ; Lim BJ; Han SH;
Clin Immunol; 2020 Feb; 211():108331. PubMed ID: 31899330
[TBL] [Abstract][Full Text] [Related]
20. Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis.
Chua JS; Zandbergen M; Wolterbeek R; Baelde HJ; van Es LA; de Fijter JW; Bruijn JA; Bajema IM
Mod Pathol; 2019 Jul; 32(8):1147-1157. PubMed ID: 30936425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
